-- Bayer Drops in Frankfurt as Nexavar Misses Main Lung Cancer Goal in Trial
-- Angela Cullen
-- 2010-06-14T07:03:32Z
-- http://www.bloomberg.com/news/2010-06-14/bayer-drops-in-frankfurt-as-nexavar-misses-main-lung-cancer-goal-in-trial.html

          
          
             Bayer AG fell as much as 1.1 percent
in Frankfurt trading after the German drugmaker said its Nexavar
cancer drug missed the main goal in a trial for lung cancer
patients.  
          
          


  
     
       
     
           
                            
                     
                     The logo of Bayer AG is seen on a smokestack at the company's plant in Leverkusen, Germany. Photographer: Wolfgang von Brauchitsch/Bloomberg  
                           

     
//<![CDATA[

            $(document).ready(function () {
        $(".view_story #story_content .attachments img.small_img").each(function(){
          var self = $(this);
          if (self.width() != 190){
            self.width(190);
        }
        });
      });
    
//]]>
